Q3 EPS Estimates for TerrAscend Increased by Seaport Res Ptn

TerrAscend Corp. (OTCMKTS:TSNDF) – Stock analysts at Seaport Res Ptn boosted their Q3 2025 earnings per share (EPS) estimates for TerrAscend in a research note issued to investors on Sunday, March 9th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings per share of ($0.03) for the quarter, up from their prior estimate of ($0.04). The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend’s FY2025 earnings at ($0.14) EPS and FY2026 earnings at ($0.13) EPS.

Separately, Atb Cap Markets cut TerrAscend from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 9th.

TerrAscend Stock Down 4.6 %

Shares of OTCMKTS TSNDF opened at $0.44 on Wednesday. The business has a 50-day simple moving average of $0.56 and a two-hundred day simple moving average of $0.85. TerrAscend has a 52 week low of $0.38 and a 52 week high of $2.20. The company has a market cap of $127.53 million, a P/E ratio of -1.55 and a beta of 1.64. The company has a quick ratio of 0.69, a current ratio of 1.35 and a debt-to-equity ratio of 0.81.

TerrAscend (OTCMKTS:TSNDF) last announced its quarterly earnings data on Thursday, March 6th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.04. The company had revenue of $74.35 million during the quarter, compared to analyst estimates of $72.37 million. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.